Implantica Financial Statements From 2010 to 2024

IMP-A-SDB  SEK 35.05  1.40  3.84%   
Implantica financial statements provide useful quarterly and yearly information to potential Implantica AG investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Implantica financial statements helps investors assess Implantica's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Implantica's valuation are summarized below:
Implantica AG does not presently have any fundamental trends for analysis.
Check Implantica financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Implantica's main balance sheet or income statement drivers, such as , as well as many indicators such as . Implantica financial statements analysis is a perfect complement when working with Implantica Valuation or Volatility modules.
  
This module can also supplement various Implantica Technical models . Check out the analysis of Implantica Correlation against competitors.

Implantica AG Company Operating Margin Analysis

Implantica's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.

Operating Margin

 = 

Operating Income

Revenue

X

100

More About Operating Margin | All Equity Analysis

Current Implantica Operating Margin

    
  (24.51) %  
Most of Implantica's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Implantica AG is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
Competition

Based on the recorded statements, Implantica AG has an Operating Margin of -24.5106%. This is 30.13% lower than that of the Healthcare sector and 37.65% lower than that of the Medical Devices industry. The operating margin for all Sweden stocks is notably higher than that of the company.

Implantica AG Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Implantica's current stock value. Our valuation model uses many indicators to compare Implantica value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Implantica competition to find correlations between indicators driving Implantica's intrinsic value. More Info.
Implantica AG is currently regarded as number one stock in return on equity category among its peers. It also is currently regarded as number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Implantica's earnings, one of the primary drivers of an investment's value.

About Implantica Financial Statements

Implantica shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Implantica investors may analyze each financial statement separately, they are all interrelated. The changes in Implantica's assets and liabilities, for example, are also reflected in the revenues and expenses on on Implantica's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Implantica AG, a medtech company, researches, develops, and sells medical implants for unmet medical needs in Switzerland. The company was founded in 2015 and is based in Vaduz, Liechtenstein. Implantica is traded on Stockholm Stock Exchange in Sweden.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Implantica Stock Analysis

When running Implantica's price analysis, check to measure Implantica's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Implantica is operating at the current time. Most of Implantica's value examination focuses on studying past and present price action to predict the probability of Implantica's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Implantica's price. Additionally, you may evaluate how the addition of Implantica to your portfolios can decrease your overall portfolio volatility.